Synchronous association of rectal adenocarcinoma and three ileal carcinoids: a case report
© McHugh et al; licensee BioMed Central Ltd. 2009
Received: 29 October 2008
Accepted: 19 February 2009
Published: 19 February 2009
Synchronous midgut carcinoids with gastrointestinal adenocarcinoma are a rare but recognised association.
The patient, a 74 year old woman, underwent anterior resection for a low rectal adenocarcinoma. Intra-operatively 3 serosal deposits of tumour were noted in the distal ileum. Histology revealed these to be ileal carcinoids.
During resection of a gastrointestinal tumour, a thorough inspection of the abdominal cavity should be undertaken to investigate the possibility of metastatic secondaries or a synchronous tumour as is reported in this case.
The natural history of midgut carcinoid tumours is to progress slowly, arising from neuro-endocrine cells that line the tract. They often present with metastasis at diagnosis and occur most frequently in the ileum (52%) and the appendix (22%) . The incidence of ileal carcinoids appears to be increasing . The concept of an association with a synchronously occurring non-carcinoid neoplasia was first broached in 1949 , and several reviews since have stressed this connection [4–7]. We present the case of a 74 year old woman who underwent elective anterior resection for a high rectal adenocarcinoma with the incidental discovery of 3 ileal carcinoids during her surgery.
Neo adjuvant chemo-radiotherapy was given to downstage the tumour and repeat MRI scan showed marked reduction of the mass lesion with no evidence of lymphadenopathy.
At laparotomy a mobile tumour was noted in the upper rectum following mobilisation. In addition three serosal deposits of tumour were noted in the distal ileum. An anterior resection was performed and 25 cm of ileum was also resected
The patient made an uncomplicated recovery and was discharged on 15 post operative day.
Two nodules of carcinoid were confirmed in the small bowel segment using immuno-staining. They both invaded to serosal level. In the third, tumour was lost on deeper sectioning but it's H&E appearance supported carcinoid. Two tiny mesenteric nodes taken were clear. The 12 cm segment of rectum showed radiation change but no residual primary mucosal lesion, demonstrating complete pathological response with 12 negative lymph nodes.
In 1888, Otto Lubarsch, a pathologist based in Berlin first described carcinoid lesions in detail. He reported the autopsy findings of a patient with multiple carcinoid tumours involving the ileum. Carcinoid syndrome and it's classic associated symptoms was reported two years later by Ransom. He described a patient with diarrhoea and wheezing secondary to an ileal carcinoid which had a distant metastasis to the liver .
The annual age-adjusted incidence of small intestine carcinoids is reported as increasing, from 1.09 per 100,000 in 1973 to 5.25 per 100,000 in 2004 . The incidental finding of malignant carcinoid at autopsy is reported at 21 per million . Surgical resection is the preferred treatment option. With regards neoadjuvant therapy, combined associations (including either 5-fluorouracil and/or streptozotocin) rarely exceed a 20% response rate .
Five year survival for resected isolated carcinoid is determined by site, with appendiceal carcinoids having a better 5 year survival prognosis (> 95%) than small intestine carcinoids (70–80%) . Recent European guidelines for surveillance of midgut carcinoids post resection with curative intent suggest follow up every 6–12 months, with the exception of grade 3 tumours which should be followed every 3 months. Minimal examinations include measurement of chromogranin A (a neuroendocrine secretory protein located in the secretory vesicles of neurons and neuroendocrine cells) and 5-Hydroxyindoleacetic acid (5-HIAA is the main metabolite of serotonin) in 24 hour urine and with three-phasic CT scan . Follow up should be life-long.
Synchronous carcinoids with non-carcinoid neoplasms in the G.I. tract were first noted by Pearson and Fitzgerald in 1949 . A study by Gerstle et al in 1995 reported on 69 patients with carcinoids of the gastrointestinal tract were discovered, of whom 29 (42 percent) had second synchronous tumours . To our knowledge this is the first report with as many as 3 midgut carcinoids discovered with a synchronous adenocarcinoma. This further cements the association elucidated by Gerstle et al.
Hypotheses put forward to explain this association include the secretion of active neuroendocrine peptides such as gastrin and cholecystokinin . Both have been previously implicated as directly regulating growth in colorectal carcinoma . Non-neuroendocrine peptides regulating cell growth and differentiation have been demonstrated in gastrointestinal carcinoid tumours and may also play a role in carcinogenesis .
In the case of a synchronous carcinoid with adenocarcinoma, management is directed towards the carcinoma, since the finding of carcinoid is incidental and so it is usually at an early stage. During resection of the colorectal tumour, a thorough inspection of the abdominal cavity should be undertaken to investigate the possibility of metastatic secondaries or a synchronous tumour as is reported in this case. Because of their slow growing natural history, the discovery of an asymptomatic gastrointestinal carcinoid during the operative treatment of another malignancy usually requires resection alone without additional treatment and will have little effect on the prognosis of the individual .
Written consent was obtained from the patient for publication of this case report
- Jenson RT: Carcinoid and pancreatic endocrine tumors: recent advances in molecular pathogenesis, localization, and treatment. Curr Opin Oncol. 2000, 12: 368-77. 10.1097/00001622-200007000-00015.View ArticleGoogle Scholar
- Maggard M, O'Connell JB, Ko CY: Updated population-based review of carcinoid tumors. Ann Surg. 2004, 240 (1): 117-22. 10.1097/01.sla.0000129342.67174.67.PubMed CentralView ArticlePubMedGoogle Scholar
- Pearson CM, Fitzgerald PJ: Carcinoid tumours: A re-emphasis of their malignant nature: Review of 140 cases. Cancer. 1949, 2: 1005-26. 10.1002/1097-0142(194911)2:6<1005::AID-CNCR2820020608>3.0.CO;2-1.View ArticlePubMedGoogle Scholar
- Lotliker U, Fogler R, Novetsky AD, Yoon NY: Concurrent colonic carcinoma and small bowel carcinoid tumour: Case reports and review of the literature. Dis Colon Rectum. 1982, 25: 375-82. 10.1007/BF02553621.View ArticleGoogle Scholar
- Brown NK, Smith MP: Neoplastic diathesis of patients with carcinoid: Report of a case with four other neoplasms. Cancer. 1973, 32: 216-22. 10.1002/1097-0142(197307)32:1<216::AID-CNCR2820320132>3.0.CO;2-5.View ArticlePubMedGoogle Scholar
- Khubchandani M, Alford JE: Primary carcinoid and carcinoma of the rectum occurring simultaneously: Report of a case. Dis Colon Rectum. 1974, 17: 117-22. 10.1007/BF02587554.View ArticlePubMedGoogle Scholar
- Sparta D, Massimilliano B, Lleshi A, Rossela F, Santo B, Salvatore B: Right colon cancer and incidental ileal carcinoid: case report. Acta Chirurgica Mediterranea. 2005, 21: 15-Google Scholar
- Sweeney JF, Rosemurgy AS: Carcinoid tumors of the gut. Cancer Control. 1997, 4 (1): 18-24.PubMedGoogle Scholar
- Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB: One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008, 26 (18): 3063-72. 10.1200/JCO.2007.15.4377.View ArticlePubMedGoogle Scholar
- Berge T, Linell F: Carcinoid tumours. Frequency in a defined population during a 12-year period. Acta Pathol Mircobio Immunol Scand [A]. 1976, 84 (4): 322-330.Google Scholar
- O'Toole D, Hentic O, Corcos O, Ruszniewski P: Chemotherapy for Gastro-Enteropancreatic Tumours. Neuroendocrinology. 2004, 80 Suppl 1: 79-84. 10.1159/000080747.View ArticlePubMedGoogle Scholar
- Sutton R, Doran HE, Williams EM, Vora J, Vinjamuri S, Evans J, Campbell F, Raraty MG, Ghaneh P, Hartley M, Poston GJ, Neoptolemos JP: Surgery for midgut carcinoid. Endocrine-Related Cancer. 2003, 469-481. 10.1677/erc.0.0100469. 10Google Scholar
- Eriksson B, Klöppel G, Krenning E, Ahlman H, Plöckinger U, Wiedenmann B, Arnold R, Auernhammer C, Körner M, Rindi G, Wildi S, Frascati Consensus Conference participants: Consensus guidelines for the management of patients with digestive neuroendocrine tumors – Well-differentiated Jejunal-ileal tumor/carcinoma. Neuroendocrinology. 2008, 87: 8-19. 10.1159/000111034.View ArticlePubMedGoogle Scholar
- Gerstle JT, Kauffman GL, Koltun WA: The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancy. J Am Coll Surg. 1995, 180: 427-32.PubMedGoogle Scholar
- Zucker KA, Longo WE, Modlin IM, Bilchik AJ, Adrian TE: Malignant diathesis from jejuno-ileal carcinoids. Am J Gastroenterol. 1989, 84: 182-186.PubMedGoogle Scholar
- Reubi JC, Schaer JC, Waser B: Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res. 1997, 57: 1377-1386.PubMedGoogle Scholar
- Habal N, Sims C, Bilchik AJ: Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol. 2000, 75: 310-316. 10.1002/1096-9098(200012)75:4<306::AID-JSO14>3.0.CO;2-3.View ArticlePubMedGoogle Scholar
- McCabe HL: Adenocarcinoma of the gastro-oesophageal junction with a synchronous carcinoid of the duodenum. Postgrad Medical Journal, BMJ. 2001, 77: 255-256. 10.1136/pmj.77.906.255.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.